首页> 美国卫生研究院文献>Schizophrenia Bulletin >Psychoeducation Improves Compliance and Outcome in Schizophrenia Without an Increase of Adverse Side Effects: A 7-Year Follow-up of the Munich PIP-Study
【2h】

Psychoeducation Improves Compliance and Outcome in Schizophrenia Without an Increase of Adverse Side Effects: A 7-Year Follow-up of the Munich PIP-Study

机译:心理教育可改善精神分裂症的依从性和结果而不会增加不良副作用:Munich PIP研究的7年随访

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Psychoeducation improves adherence and motivates patients to accept a maintenance therapy as recommended by the guidelines. This would mean a daily consumption of at least 300 chlorpromazine (CPZ) units in the long run and should lead to an increase of the antipsychotic dosage in comparison to patients with treatment as usual (TAU). This raises 2 important questions: whether more side effects are provoked and do the patients have a corresponding benefit with a better outcome. A total of 41 patients with a diagnosis of schizophrenic or schizoaffective disorder were randomized at study entry, either to bifocal psychoeducation (21), or to standard treatment (20). They were compared concerning compliance, type of medication, dosage (CPZ equivalents), motor side effects and number of days in hospital. The average daily antipsychotic medication 2 and 7 years after index discharge was 365 and 354 CPZ-units respectively in the intervention group (IG), but 247 and 279, respectively in the control group (CG). The extent of motor side effects was slightly smaller in the IG, but they showed a small and statistically not significant increase in the rate of tardive dyskinesia (TD) after 7 years. At the 7-year follow-up the patients in the IG had spent 74.7 days in hospital compared to 243.4 days for the patients in the CG (P < .05). The course of illness was significantly better in the IG without increasing motor side-effects. Therefore, psychoeducation should be integrated more systematically into the routine treatment. These data are part of a previous study, published 2007, with a sample size of 48 patients. Seven patients—3 of the IG and 4 of the CG—could not be included, because they were not able to complete the very complex “Computer-based kinematic analysis of motor performance.” In this article all conclusions are referred to the new sample size, therefore some results are slightly different in comparison to the previous data.
机译:心理教育可改善依从性,并激励患者接受指南建议的维持治疗。从长远来看,这意味着每天至少要消耗300氯丙嗪(CPZ)单位,并且与常规治疗(TAU)的患者相比,应导致抗精神病药物剂量的增加。这就提出了两个重要的问题:是否会引起更多的副作用,以及患者是否具有相应的获益且预后更好。共有41例被诊断为精神分裂症或精神分裂性情感障碍的患者在研究入选时被随机分为双焦点心理教育(21)或标准治疗(20)。比较了他们的依从性,药物类型,剂量(CPZ当量),运动副作用和住院天数。指数释放后2年和7年的平均每日抗精神病药物干预组(IG)分别为365和354个CPZ单位,而对照组(CG)分别为247和279个CPZ单位。在IG中,运动副反应的程度略小,但7年后,它们显示迟发性运动障碍(TD)的发生率在统计学上不大,增加幅度很小。在7年的随访中,IG患者的住院时间为74.7天,而CG患者为243.4天(P <.05)。 IG的病程明显好转,而没有增加运动副作用。因此,应将心理教育更系统地纳入常规治疗。这些数据是先前发表于2007年的研究的一部分,样本量为48位患者。由于无法完成非常复杂的“基于计算机的运动功能运动学分析”,因此无法纳入7名患者,其中3名是IG,3名是CG。本文中的所有结论均涉及新的样本量,因此与先前数据相比,某些结果略有不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号